Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-26T08:37:37.763Z Has data issue: false hasContentIssue false

Antitumour immune responses

Published online by Cambridge University Press:  13 February 2004

Roshni Mitra
Affiliation:
Centre for Cellular and Molecular Biology, Uppal Road, Hyderabad 500 007, India.
Sarvjeet Singh
Affiliation:
Centre for Cellular and Molecular Biology, Uppal Road, Hyderabad 500 007, India.
Ashok Khar
Affiliation:
Centre for Cellular and Molecular Biology, Uppal Road, Hyderabad 500 007, India.

Abstract

The role of the immune system in combating tumour progression has been studied extensively. The two branches of the immune response – humoral and cell-mediated – act both independently and in concert to combat tumour progression, the success of which depends on the immunogenicity of the tumour cells. The immune system discriminates between transformed cells and normal cells by virtue of the presence of unique antigens on tumour cells. Despite this, the immune system is not always able to detect and kill cancerous cells because neoplasms have also evolved various strategies to escape immune surveillance. Attempts are being made to trigger the immune system into an early and efficient response against malignant cells, and various therapeutic modalities are being developed to enhance the strength of the immune response against tumours. This review aims to elucidate the tumouricidal role of various components of the immune system, including macrophages, lymphocytes, dendritic cells and complement.

Type
Review Article
Copyright
© Cambridge University Press 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)